Metabolism, autophagy, and cell death: The triangular axis in tumor survival and therapeutic resistance

Wen-Dong Wan1, Muhammad Tufail1, Can-Hua Jiang2

  • 1Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China.

Redox Biology
|June 25, 2026
PubMed

Insights

Tumor cells use autophagy, metabolism, and cell death regulation to survive stresses and resist treatments. Understanding this interplay is key to developing effective cancer therapies and overcoming drug resistance.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metabolism

Background:

  • Tumor cells constantly face environmental and therapeutic stresses.
  • Interconnected survival mechanisms involving autophagy, metabolism, and cell death regulation are crucial for tumor cell adaptation.

Purpose of the Study:

  • To explore the triangular relationship between autophagy, metabolism, and cell death regulation in cancer.
  • To understand how this interplay supports tumor growth and treatment resistance.

Main Methods:

  • Review of key molecular pathways regulating autophagy.
  • Analysis of metabolic reprogramming in cancer cells.
  • Examination of the impact on different cell death modalities.

Main Results:

  • The dynamic interplay between autophagy, metabolism, and cell death supports tumor progression.
  • This network contributes significantly to resistance against various cancer treatments.
  • Specific molecular pathways governing these processes have been identified.

Conclusions:

  • Understanding the complex network of autophagy, metabolism, and cell death offers promising avenues for novel cancer therapies.
  • Overcoming treatment resistance requires precise biomarkers and effective combination strategies.
  • Translating this knowledge into clinical practice remains a significant challenge.

Related Concept Videos

Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...